Stockholm, Sweden
Sat 16 09:20
Cambridge, UK
Sat 16 12:25
S4.3
Statins and Cardiovascular risk in T1D
Cambridge, UK
Leipzig, Germany
Stockholm, Sweden
Sun 17 08:30
C1.1
Should we restrict height in tall stature? - FOR
Stockholm, Sweden
Cambridge, UK
Sat 16 12:25
S4.3
Statins and Cardiovascular risk in T1D
Cambridge, UK
Boston, USA
Sun 17 16:10
PL5
Cambridge, UK
Leipzig, Germany
Sat 16 14:40
RFC1.4
Children born small for gestational age (SGA) under growth hormone treatment have similarly impaired glucose-insulin metabolism as children with obesity
Leipzig, Germany
kanpur, India
Sat 16 14:30
RFC5.2
The development and validation of Bone age-guided Interpretation of Growth (BIG), a web-based tool for the guidance of evaluation of children and adolescents with growth disorders.
kanpur, India
Sheffield, United Kingdom
Sat 16 14:55
FC4.1
Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH).
Sheffield, United Kingdom
Copenhagen, Denmark
Sat 16 15:45
FC3.6
Adolescent Acne: Association to Sex, Age, Pubertal Stage and Circulating Concentrations of Testosterone and DHT
Copenhagen, Denmark
Giessen, Germany
Sun 17 10:10
FC8.2
Detection and differentiation of adrenocortical tumors (ACTs) in children by gas chromatography-mass spectrometry (GC-MS) based urinary steroid metabotyping
Giessen, Germany
Istanbul, TURKEY
Mon 18 09:05
RFC14.2
Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?
Istanbul, TURKEY
Milan, Italy
Mon 18 09:20
RFC12.5
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Alexandria, Egypt
Sat 16 14:30
RFC1.2
Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus.
Alexandria, Egypt
Alexandria, Egypt
Herlev, Denmark
Mon 18 10:10
FC15.5
Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities
Herlev, Denmark
Muscat, Oman
Sun 17 09:35
RFC10.2
Ten-year follow up for Children with non-lethal form of Raine Syndrome: Single Center Experience in Oman
Muscat, Oman
Doha, Qatar
Sun 17 09:45
RFC6.4
Investigation of GNAS Variations as Causes of Monogenic Obesity in Qatar: An Integrative Approach Utilizing In Silico, In Vivo, and In Vitro Studies
Doha, Qatar
Riyadh, Saudi Arabia
Sun 17 10:50
FC10.6
Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective
Riyadh, Saudi Arabia
London, UK
Mon 18 09:40
FC13.2
Copy Number Variation (CNV) in Self-limited Delayed Puberty (SLDP)
London, UK
Istanbul, Turkey
Sun 17 09:55
RFC10.6
Different Faces of Carney Complex: Report of Three Cases
Istanbul, Turkey
Edinburgh, UK
Sat 16 09:00
Fertility preservation in girls
Edinburgh, UK
Genova, Italy
Sat 16 14:25
RFC2.1
Bone and Body Composition after one year of Vosorotide treatment in children with Achondroplasia: a longitudinal prospective study.
Genova, Italy
Izmir, Turkey
Mon 18 10:10
FC12.5
The Association between Plasma Thyroxine Levels and Attention-Deficit/Hyperactivity Disorder
Izmir, Turkey
Prague, Czech Republic
Sat 16 14:55
FC5.1
A homozygous variant in ZSWIM6 causes short stature, microcephaly and developmental delay
Prague, Czech Republic
Cairo, Egypt
Sun 17 09:55
RFC8.6
Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH).
Cairo, Egypt
Cairo, Egypt
Madrid, Spain
Sat 16 11:55
S3.2
Use of MC4R agonist in hypothalamic obesity
Madrid, Spain
Madrid, Spain
Sun 17 10:10
FC6.2
Frequency of Bardet-Biedl syndrome variants in a population with early-onset obesity
Madrid, Spain
Mon 18 09:40
FC11.2
Frequency of rare non-syndromic diseases in a population with early-onset obesity
Madrid, Spain
Cairo, Egypt
Sun 17 09:55
RFC8.6
Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH).
Cairo, Egypt
Cairo, Egypt
Michigan, USA
Sun 17 14:30
S5.1
Rotterdam, The Netherlands
Sat 16 15:35
FC4.5
3D printed, personalized hydrocortisone for hypocortisolemia.
Rotterdam, The Netherlands
Cincinnati, USA
Sat 16 08:20
Beyond growth and puberty issues in girls with TS
Cincinnati, USA
Birmingham, UK
Sat 16
Partial gonadal dysgenesis due to chromosomal mosaicism – a challenging case
Birmingham, UK
Manchester, UK
Mon 18 10:00
FC14.4
Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
Manchester, UK
Linköping, Sweden
Sat 16 15:45
FC5.6
First line treatment evaluation in patients with severe primary insulin-like growth factor 1 deficiency (SPIGFD): Data from the Global Increlex® Registry
Linköping, Sweden
Philadelphia, USA
Mon 18 16:00
S9.2
Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data
Philadelphia, USA
Parma, Italy
Sun 17 10:20
FC7.3
Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height
Parma, Italy
Copenhagen, Denmark
Sun 17 10:20
FC9.3
Prenatal exposure to paracetamol is associated with reduced uterine volume at infancy - A COPANA Cohort study of 302 healthy girls
Copenhagen, Denmark
Rome, Italy
London, United Kingdom
Sat 16 15:05
FC3.2
Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma
London, United Kingdom
Montreal, Canada
Mon 18 09:00
RFC11.1
Assessing how the Edmonton Obesity Staging System for Pediatrics (EOSS-P) in childhood relates to later cardiometabolic health compared to other anthropometric measures of obesity
Montreal, Canada
London, UK
Mon 18 15:30
S10.1
Hypothalamic dysfunction in PWS – research perspective
London, UK
Leuven, Belgium
Sun 17 08:35
MTE6.1
Mon 18 14:15
MTE6.2
Bern, Switzerland
Mon 18 09:15
RFC15.4
Autoimmunity in children with type 1 diabetes in association with the COVID_19 pandemic - results from the prospective DPV Registry
Bern, Switzerland
Warsaw, Poland
Sat 16 15:15
FC3.3
Analysis of clinical factors affecting retinal ganglion cell complex thickness reduction in patients with childhood‑onset craniopharyngioma.
Warsaw, Poland
Amsterdam, The Netherlands
Sun 17 10:40
FC9.5
Sex hormones shape the skeleton: The impact of puberty suppression and gender affirming hormone therapy on skeletal dimensions in transgender individuals
Amsterdam, The Netherlands
Bologna, Italy
Mon 18 09:30
FC12.1
Use of targeted Next-Generation Sequencing panel in patients with non-autoimmune hypothyroidism: the experience of an Italian Pediatric Endocrinology Center
Bologna, Italy
Bialystok, Poland
Mon 18 09:25
RFC12.6
Evaluation of thyroid nodules in children and adolescents by shear wave elastography (SWE)
Bialystok, Poland
Białystok, Poland
Mon 18 09:50
FC12.3
Usefulness of application novel TurboTM TSAb bioassay in the monitoring of pediatric Graves’ patients
Białystok, Poland
Bron, France
Sun 17 09:30
RFC9.1
Prenatal Steroid profiling in 46,XY Disorders of sexual Development (DSD) : A 10 year Retrospective Cohort study
Bron, France
Exeter, United Kingdom
Mon 18 09:30
FC14.1
Non-invasive prenatal testing can detect maternally and paternally inherited variants in the KCNJ11 and ABCC8 genes: implications for clinical management of neonatal diabetes during pregnancy and beyond
Exeter, United Kingdom
Brussels, Belgium
Sun 17 10:20
FC8.3
Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant
Brussels, Belgium
London, United Kingdom
Sun 17 10:30
FC6.4
Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome
London, United Kingdom
MODENA, ITALY
Sun 17 09:40
RFC10.3
Anthropometric changes in survivors of childhood acute lymphoblastic leukemia treated on the Italian Association of Pediatric Hematology and Oncology protocols without radiotherapy in the last two decades: preliminary data from an Italian tertiary center.
MODENA, ITALY
Liverpool, United Kingdom
Sat 16 14:40
RFC4.4
Serum cortisol correlates strongly with salivary cortisol and cortisone in girls and boys, and across all ages
Liverpool, United Kingdom
Buenos Aires, Argentina
Sun 17 09:45
RFC9.4
Testicular function in prepubertal boys with haematological malignancies during and post chemotherapy: a prospective, longitudinal study
Buenos Aires, Argentina
Michigan, USA
Sun 17 14:30
S6.1
Molecular Basis of Congenital Hypopituitarism
Michigan, USA
Piacenza, Italy
Mon 18 10:00
FC12.4
Docosahexaenoic acid (DHA) is reduced and could be protective against Hashimoto’s thyroiditis in children with Down syndrome: a cross-sectional study
Piacenza, Italy
Sao Paulo, Brazil
Mon 18 09:50
FC15.3
Assessment of actionable secondary genetic findings in a large cohort of children with short stature
Sao Paulo, Brazil
London, UK
Sun 17 15:30
S6.3
Management of pituitary stalk thickening in children and young people
London, UK
London, United Kingdom
Mon 18 09:05
RFC13.2
Novel anatomical quantification of all hypothalamic, pituitary, and stalk components predicts the severity of neuroendocrine phenotypes.
London, United Kingdom
Mon 18 09:10
RFC13.3
Unstimulated copeptin and oxytocin concentrations correlate with hypothalamic volumes and posterior pituitary location in congenital and acquired salt-water imbalance disorders.
London, United Kingdom
Essen, Germany
Mon 18 09:10
RFC11.3
Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome
Essen, Germany
Lille, France
Mon 18 15:30
S12.1
The Role of MiniPuberty in Non-Reproductive Outcomes
Lille, France
Solna, Sweden
Sat 16 08:10
Athens, Greece
Chicago, USA
Sat 16 08:30
Mental health/psychosocial outcomes versus mental health and brain effects
Chicago, USA
Shanghai, China
Sat 16 14:45
RFC2.5
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Hangzhou, China
Sat 16 15:15
FC2.3
Molecular mechanism of FBN1 variants result to acromicric dysplasia by mechano-transduction
Hangzhou, China
Guangzhou, China
Mon 18 09:50
FC13.3
Effect of Precocious Puberty and GnRHa Treatment on Glucose Metabolism in Female Rats
Guangzhou, China
Chicago, USA
Mon 18 16:30
S11.3
Bari, Italy
Mon 18 09:50
FC11.3
Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters
Bari, Italy
Ghent, Belgium
Sat 16 09:00
CORE ENDOCRINE REGISTRY: transgender module – preliminary data and future plans
Ghent, Belgium
Rome, Italy
Ixelles, Belgium
Sat 16 11:55
S4.2
Use of GLP1 receptor agonists in Wolfram syndrome
Ixelles, Belgium
Milan, Italy
Sun 17 10:20
FC10.3
Endocrine disorders in a wide cohort of children and adolescents affected by Neurofibromatosis type 1
Milan, Italy
Ghent, Belgium
Sat 16
Pathophysiology and Management of Dysgenetic Gonads
Ghent, Belgium
Toledo, Spain
Sun 17 09:30
RFC7.1
Understanding the molecular basis of short stature in Fanconi Anemia: Impact of pappalysins and stanniocalcins on IGF-I bioavailability
Toledo, Spain
Cambridge, United Kingdom
Mon 18 10:20
FC14.6
Patient and Carer Perspectives: A National Survey of Continuous Glucose Monitoring in Children with Congenital Hyperinsulinism in the UK
Cambridge, United Kingdom
Liverpool, UK
Sat 16 14:25
RFC4.1
Screening for Adrenal Insufficiency in Children by Home Waking Salivary Cortisone testing
Liverpool, UK
Genoa, Italy
Mon 18 09:05
RFC11.2
Is the Single Point Insulin Sensitivity Estimator (SPISE) index a reliable tool for children and adolescents with overweight/obesity?
Genoa, Italy
London, UK
Mon 18 09:50
FC14.3
Reduction of Overnight Hypoglycemia in Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study
London, UK
Luxembourg, Luxembourg
Paris, France
Mon 18 09:30
FC13.1
Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism
Paris, France
Manchester, United Kingdom
Mon 18 09:25
RFC14.6
Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism
Manchester, United Kingdom
Montreal, Canada
Bursa, Turkey
Mon 18 09:00
RFC12.1
From neurology to endocrine: Misdiagnosed MCT8 deficiency
Bursa, Turkey
Aydın, Turkey
Sat 16 14:45
RFC1.5
Evaluation of Arterial Stiffness in Children with Type 1 Diabetes Mellitus Using Speckle Tracking Carotid Strain Ultrasonography: Do Atherosclerotic Changes Begin in Childhood?
Aydın, Turkey
Genoa, Italy
Stockport, UK
Mon 18 10:20
FC12.6
The First Robust Bioavailability/Bioequivalence (BA/BE) Study of Thyromimetic Tiratricol, a Treatment in Development for MCT8 Deficiency.
Stockport, UK
Vitoria, Spain
Sun 17 09:55
RFC7.6
Big data as a strategy in the development of population auxological studies
Vitoria, Spain
ALGIERS, ALGERIA
Sun 17 09:45
RFC7.4
Use of iSYS-IDS IGF1-Assay Normative Data as a STANDARD in the Diagnosis of Pediatric Growth Hormone Deficiency
ALGIERS, ALGERIA
Rotterdam, The Netherlands
Mon 18 10:20
FC11.6
Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years
Rotterdam, The Netherlands
Manchester, United Kingdom
Mon 18 09:40
FC15.2
Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)
Manchester, United Kingdom
Copenhagen, Denmark
Sun 17 10:50
FC8.6
Plasma concentrations of renin and ACTH in children and adolescents from the general population: new reference intervals according to sex, age, and pubertal stage
Copenhagen, Denmark
İstanbul, Turkey
Sat 16 15:05
FC2.2
Therapeutic Effects of Human Bone Marrow Mesenchymal Stem Cells Derived Exosomes on Glucocorticoid-Induced Osteoporosis: In Vitro Model
İstanbul, Turkey
Ribeirão Preto, Brazil
Sun 17 09:50
RFC8.5
Mitochondrial Nicotinamide Nucleotide Transidrogenase (NNT) and NNT-AS1 impairment is associated with worse outcomes in patients with adrenocortical tumors
Ribeirão Preto, Brazil
Shanghai, China
Sat 16 14:55
FC2.1
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
ATHENS, GREECE
Sun 17 10:30
FC10.4
A novel de novo SAMD9 gene variant causing MIRAGE syndrome associated with steroid-resistant nephrotic syndrome in a 46,XY male.
ATHENS, GREECE
Cambridge, UK
Genova, Italy
Sun 17 10:30
FC7.4
Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
Genova, Italy
Petach Tikva, Israel
Sat 16 15:25
FC5.4
Predictors of short stature at age 6-7 years in Israeli children
Petach Tikva, Israel
Switzerland
Colorado , USA
Sat 16 11:25
S4.1
Use of Verapamil in newly diagnosed T1D
Colorado , USA
Pavia, Italy
Sat 16 08:35
Osteogenesis imperfecta, update and the OI XIV Animal model
Pavia, Italy
Nesoddtangen, Norway
Sun 17 15:30
S7.3
Consensus statement on management of achondroplasia
Nesoddtangen, Norway
Zhejiang, China
Sat 16 08:15
Pubertal Development in Chinese Children and the Impact of Overnutrition, Lifestyle, and Perinatal Factors
Zhejiang, China
Shanghai, China
Sat 16 14:55
FC2.1
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Doha, Qatar
Sun 17 10:00
FC6.1
Corneal Nerve Loss and regeneration after GLP-1 Therapy in Children with Simple and Monogenic Obesity
Doha, Qatar
Washington DC, United States of America (USA)
Sat 16 15:35
FC5.5
Phase 2 Trial of Vosoritide Use in patients with Hypochondroplasia: Pharmacokinetic/ Pharmacodynamic analysis from 12 Month Data
Washington DC, United States of America (USA)
London, UK
Sat 16 11:25
S3.1
National UK Guidelines for the Management of Paediatric Craniopharyngioma
London, UK
Manchester, United Kingdom
Mon 18 09:30
FC15.1
Response to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables
Manchester, United Kingdom
Leipzig, Germany
Sun 17 09:35
RFC6.2
Genetic Diagnostic Yield of Obesity
Leipzig, Germany
Mon 18 09:15
RFC11.4
Association of whole blood amino acid and acylcarnitine metabolome with anthropometry and IGF1 serum levels in healthy children and adolescents
Leipzig, Germany
London, UK
Katowice, Poland
Sat 16 09:00
To present multi-central experience/data and invite to prospective study
Katowice, Poland
Sat 16 14:50
RFC5.6
Pubertal induction in girls with Turner syndrome – retrospective data from the International TS registry
Katowice, Poland
Chandigarh, India
Sat 16 15:05
FC1.2
EFFECT OF HYDROXYCHLOROQUINE THERAPY IN NEWLY DIAGNOSED TYPE 1 DIABETES: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROL PILOT TRIAL
Chandigarh, India
London, UK
Mon 18 10:00
FC11.4
Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies
London, UK
Chieti, Italy
Girona, Spain
Sun 17 09:55
RFC6.6
POTENTIAL ROLE OF ASPG METHYLATION AS A BIOMARKER OF CHILDHOOD OBESITY
Girona, Spain
Rotterdam, The Netherlands
Sat 16 14:25
RFC5.1
ABOUT CARING FOR PATIENTS AND UNDERSTANDING THEIR PATHWAYS: 10 YEARS OF ‘THE ROTTERDAM CENTRE FOR ADULTS WITH RARE GENETIC SYNDROMES’
Rotterdam, The Netherlands
Naples, Italy
Sat 16 14:25
RFC3.1
DNA Methylation profiles in girls with anorexia nervosa and amenorrhea: a pilot study
Naples, Italy
Mon 18 09:25
RFC15.6
Macrophage switch and iron metabolism regulation by Burosumab in XLH pediatric patients: implications in inflammation and pain modulation.
Naples, Italy
Aarhus, Denmark
Sat 16 08:40
Challenges from the adult endocrinologist perspective
Aarhus, Denmark
Prague, Czech republic
Sat 16 14:45
RFC5.5
Searching for associated dysmorphic and cardiac abnormalities in youth tall basketball players
Prague, Czech republic
London, United Kingdom
Sat 16 14:30
RFC3.2
Results from a targeted hypopituitarism gene panel in patients with variable congenital hypopituitarism identifies variants in known and novel candidate genes.
London, United Kingdom
Ramat Gan, Israel
Sun 17 09:50
RFC9.5
Reevaluating Guidelines for Primary Ovarian Insufficiency Workup: Is It Time for a Change?
Ramat Gan, Israel
Padova, Italy
Sat 16 14:35
RFC2.3
Optimizing the Growth Outcome follow up in Hypophosphatemic Rickets Treated with Burosumab: The Critical Role of Auxological Measurements
Padova, Italy
Istanbul, Turkey
Istanbul, Turkey
Sat 16 14:50
RFC4.6
Machine Learning-Based Decision Tree Model for the Diagnosis of Congenital Disorders of Adrenal Steroidogenesis Using LC-MS/MS-based Plasma Steroid Hormone Profiles
Istanbul, Turkey
Liestal, Switzerland
Sun 17 09:55
RFC9.6
GnRHa TREATMENT OF CRYPTORCHIDISM ALTERS TESTICULAR SUMO GENE EXPRESSION
Liestal, Switzerland
Mon 18 09:00
RFC15.1
Altered expression of epigenetic regulators is associated with high infertility risk in patients diagnosed with cryptorchidism.
Liestal, Switzerland
Copenhagen, Denmark
Sun 17 10:00
ES1.2
Prenatal Exposure to Over-the-Counter Antifugal Drugs Affects Fetal Steroidogenesis and is Associated with Persistent Effects in Children
Copenhagen, Denmark
Shanghai, China
Sat 16 14:55
FC2.1
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Jinan, China
Mon 18 10:10
FC11.5
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
London, UK
Sat 16 16:55
NA1
Relevance of single cell analysis and spatial transcriptomics for endocrine research to unravel new mechanisms?
London, UK
Istanbul, Turkey
Sun 17 09:35
RFC8.2
A Novel Peroxisomal Cause of Primary Adrenal İnsufficiency: Pseudo-neonatal Adrenoleukodystrophy Due to ACOX1 Mutations.
Istanbul, Turkey
Lübeck, Germany
Cambridge, UK
Mon 18 16:00
S10.2
Long-term management and outcomes in PWS
Cambridge, UK
Gothenburg, Sweden
Sat 16 14:40
RFC5.4
Analysis of growth patterns in Klinefelter syndrome using the QEPS growth model
Gothenburg, Sweden
Exeter, United Kingdom
Mon 18 10:10
FC14.5
A novel 94bp deletion in the SLC16A1 promoter causes fasting and exercise-induced hyperinsulinaemic hypoglycaemia
Exeter, United Kingdom
Dublin, Ireland
Mon 18 09:15
RFC12.4
Establishing Outcomes and Management of Mild Neonatal Hyperthyrotropinaemia, a Retrospective Multi-Centre Review
Dublin, Ireland
Stockholm, Sweden
Mon 18 16:30
S10.3
Growth hormone treatment in adults with PWS
Stockholm, Sweden
Shanghai, China
Sat 16 14:55
FC2.1
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Birmingham, United Kingdom
Sat 16 15:05
FC4.2
11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in ex vivo culture
Birmingham, United Kingdom
London, UK
Sun 17 15:00
S7.2
Genetic disorders of bone - historic perspectives and novel advances
London, UK
London, United Kingdom
Mon 18 10:00
FC15.4
Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality
London, United Kingdom
Bron, France
Sun 17 10:30
FC8.4
A deep intronic splice variant of CYP11B1 is the most common in Caucasian patients with 11-beta hydroxylase deficiency: functional, clinical and hormonal findings in 36 families
Bron, France
Prague, Czech Republic
Sun 17 10:10
FC7.2
Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups
Prague, Czech Republic
Copenhagen, Denmark
Mon 18 10:20
FC13.6
Voice frequency in healthy children and adolescents: A biomarker of androgen action in puberty
Copenhagen, Denmark
Izmir, Turkey
Sat 16 15:15
FC1.3
A Non-Invasive Diagnostic Tool for Early Detection of Microvascular Alterations in Children with Type 1 Diabetes Mellitus: Nail-Fold Capillaroscopy
Izmir, Turkey
Istanbul, Turkey
Sun 17 09:30
RFC10.1
Long-Term Endocrine Outcomes of Acute Lymphoblastic Leukemia Treatment with Special Emphasis on the Gonadal Impact
Istanbul, Turkey
Istanbul, Turkey
Sun 17 09:40
RFC8.3
Multi-hit Model of Primary Adrenal Insufficiency in CPOX mutations
Istanbul, Turkey
Alexandria, Egypt
Sat 16 14:30
RFC1.2
Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus.
Alexandria, Egypt
Alexandria, Egypt
Ankara, Turkey
Sat 16 14:55
FC3.1
The Effects of Blue Light Exposure on the Epiphyseal Plate and IGF1 - IGFBP3 Expression in Rats
Ankara, Turkey
Ankara, Turkey
Mon 18 09:40
FC12.2
Molecular Characterization of Childhood Thyroid Nodules and Thyroid Cancer with DNA/RNA Next Generation Sequencing and Investigation of Phenotype-Genotype Correlation
Ankara, Turkey
Istanbul, Turkey
Mon 18 09:15
RFC13.4
Investigation of Pituitary Function in Langerhans Cell Histiocytosis: A Comprehensive Analysis of Clinical and Radiological Findings
Istanbul, Turkey
Leipzig, Germany
Mon 18 09:25
RFC11.6
Pten knockout in osteoprogenitor cells leads to loss of adipose tissue
Leipzig, Germany
Izmir, Turkey
Sat 16 14:55
FC1.1
Does Type 1 Diabetes Effect Left Ventricular Function in Children? Evaluation with Treadmill Exercise Stress Echocardiography
Izmir, Turkey
Copenhagen, Denmark
Sun 17 09:30
ES1.1
Endocrine disrupting effects of over-the-counter mild analgesics such as paracetamol in humans
Copenhagen, Denmark
Umea, Sweden
Sat 16 08:00
News and doubts around growth and puberty therapy
Umea, Sweden
Sheffield, UK
Sun 17 15:30
S5.3
Lessons from CAH service evaluation and real world data
Sheffield, UK
Augsburg, Germany
Sun 17 10:00
FC8.1
Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways
Augsburg, Germany
Kiel, Germany
Sat 16 15:15
FC4.3
Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort
Kiel, Germany
Istanbul, Turkey
Sat 16 14:40
RFC2.4
CYP24A1 MUTATIONS:, CLINICAL AND LABORATORY FEATURES IN PATIENTS PRESENTING WITH HYPERCALCEMIA
Istanbul, Turkey
São Paulo, Brazil
Mon 18 16:00
S12.2
Neurodevelopmental syndromes associated with Centra Precocious Puberty
São Paulo, Brazil
London, UK
Tel Aviv, Israel
Paris, France
Mon 18 16:00
S11.2
MAIT cells, an immune link between microbiota and type 1 diabetes
Paris, France
Shanghai, China
Mon 18 09:05
RFC15.2
Study on effects of poly- and perfluoroalkyl substances on hormones in girls with central precocious puberty
Shanghai, China
Paris, France
Sat 16 12:25
S2.3
PTH Resistance Syndromes
Paris, France
Örebro, Sweden
Sat 16 14:45
RFC3.5
Long-Term Health Outcomes of Delayed Puberty in Males: A Comprehensive Population-Based Study
Örebro, Sweden
Girona, Spain
Sun 17 09:50
RFC6.5
GRB10 METHYLATION IN UMBILICAL CORD ASSOCIATES POSTNATALLY WITH OBESITY IN HEALTHY CHILDREN
Girona, Spain
Lausanne, Switzerland
Sat 16 14:50
RFC2.6
Comparison of two automated bone age evaluation methods in pediatric patients with growth and puberty disorders
Lausanne, Switzerland
Glasgow, UK
Sat 16 11:25
S1.1
Vascular reactivity and morbidity in DSD
Glasgow, UK
Brussels, Belgium
Exeter, United Kingdom
Sat 16 15:45
FC1.6
Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort
Exeter, United Kingdom
Utrecht, Netherlands
Mon 18 09:10
RFC15.3
The different faces of acquired hypothalamic dysfunction.
Utrecht, Netherlands
London, United Kingdom
Sat 16 15:05
FC5.2
The pathogenesis of Noonan syndrome and associated growth restriction is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling
London, United Kingdom
London, United Kingdom
Sun 17 10:40
FC7.5
Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment
London, United Kingdom
Basildon, United Kingdom
Sat 16 15:35
FC1.5
The Side-Effects of Lanreotide in Children with Congenital Hyperinsulinism (CHI): A Decade-long Exploration
Basildon, United Kingdom
Sat 16 15:25
FC3.4
The spectrum of Endocrinopathies in Children with Ectopic Posterior Pituitary (EPP) correlates with the severity of associated hypothalamo-pituitary abnormalities on imaging: a decade long experience from two tertiary centers.
Basildon, United Kingdom
Baku, Azerbaijan
Mon 18 09:10
RFC12.3
Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism
Baku, Azerbaijan
Verona, Italy
Sat 16 14:50
RFC1.6
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND ITS ASSOCIATION WITH GLYCEMIC CONTROL METRICS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: AN EXPLORATORY STUDY
Verona, Italy
Rome, Italy
Mon 18 09:30
FC11.1
Frequency of rare syndromic diseases in a population with early-onset obesity
Rome, Italy
Agios Nikolaos, Greece
Sat 16 15:45
FC4.6
Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study
Agios Nikolaos, Greece
Paris, France
Sat 16 11:55
S1.2
Novel mechanisms leading to DSD (genomic, digenic/ollogenic and non-coding variation)
Paris, France
London, United Kingdom
Sun 17 10:00
FC9.1
A tiered approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
London, United Kingdom
Sun 17 10:10
FC10.2
Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918TRET pathogenic variants in children and young people
London, United Kingdom
Liverpool, United Kingdon
Sat 16 14:30
RFC4.2
Salivary cortisol and cortisone is related to age
Liverpool, United Kingdon
Los Angeles , USA
Sat 16 10:15
PL1
São Paulo, Brazil
Sat 16 08:00
Tennessee, USA
Sat 16 12:25
S3.3
Proton Beam Therapy in childhood brain tumours
Tennessee, USA
Boston, USA
Sun 17 15:30
S8.3
Bariatic surgery: impact beyond weight
Boston, USA
Magdeburg, Germany
Sat 16 15:45
FC2.6
Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment
Magdeburg, Germany
Copenhagen, Denmark
Sun 17 10:30
FC9.4
Prenatal exposure to paracetamol is associated with smaller testis volume and decreased levels of steroid metabolites during infancy in healthy males: A COPANA cohort study of 287 boys
Copenhagen, Denmark
Verona, Italy
Mon 18 09:20
RFC11.5
Hepatic lipogenesis increases FGF21 in children/adolescents with obesity.
Verona, Italy
Dubai , UAE
Sun 17 08:35
MTE8.1
Mon 18 08:00
MTE8.2
Khartoum, Sudan
Sun 17 09:45
RFC8.4
Rare Genetic Etiology of Primary Adrenal Insufficiency in Children; Clinical and Genetic Characterization Of a Large Sudanese Cohort
Khartoum, Sudan
Tottori, Japan
Sat 16 15:25
FC2.4
Analysis of baseline data from the SUNFLOWER longitudinal, observational cohort study of patients with XLH: relationship between various complications and QOL
Tottori, Japan
Kaunas, Lithuania
Sun 17 09:45
RFC10.4
Manifestation of PTEN and MUTYH gene mutations: A Case Report
Kaunas, Lithuania
Berlin, Germany
Sun 17 09:30
RFC8.1
PREDICT – A randomized investigation of a reduced prenatal dexamethasone dose to reduce virilization in female fetuses with congenital adrenal hyperplasia
Berlin, Germany
Stockholm, Sweden
Sat 16 12:25
S1.3
Hypospadias - surgery and beyond
Stockholm, Sweden
Cardiff, United Kingdom
Sat 16 14:25
RFC1.1
Perceptions and Experiences of PDSNs on Different Hybrid Closed Loop Systems (HCLS) across Wales
Cardiff, United Kingdom
Milan, Italy
Mon 18 16:30
S12.3
Studying the genetic interplay between GnRH deficiency and associated neurocognitive disorders by combining in silico, in vitro and in vivo tools.
Milan, Italy
Texas, USA
Sun 17 14:30
S7.1
Stem cells in skeletal development and growth
Texas, USA
London, United Kingdom
Sun 17 10:00
FC10.1
Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes
London, United Kingdom
Nijmegen, Netherlands
Sun 17 10:40
FC8.5
Free cortisol and free 21-deoxycortisol in the clinical evaluation of adrenal insufficiency in congenital adrenal hyperplasia
Nijmegen, Netherlands
Rome, Italy
Liège, Belgium
Sun 17 10:30
ES1.3
Effect of EDCs on the hypothalamic regulation of energy homeostasis and GnRH activity
Liège, Belgium
Genova, Italy
Sat 16 14:35
RFC5.3
Neuroradiological Findings in Noonan Syndrome: a multicentric Italian study
Genova, Italy
London, UK
Sat 16 08:00
Immunological effects of gender affirming hormone treatment
London, UK
Szczecin, Poland
Sun 17 10:50
FC7.6
Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment
Szczecin, Poland
Helsinki, Finland
Sat 16 15:35
FC2.5
Bone health in adolescents with cow’s milk allergy during infancy
Helsinki, Finland
Tel Aviv, Israel
Paris, France
Mon 18 15:30
S9.1
Challenges in congenital hypothyroidism: including genetics, newborn screening and treatment optimization
Paris, France
Tennessee, USA
Mon 18 11:00
PL6
Pancreatic and islet plasticity in early life: implications for diabetes risk
Tennessee, USA
Mumbai, India
Mon 18 09:15
RFC14.4
Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant.
Mumbai, India
Guangzhou, China
Sat 16 14:35
RFC1.3
Akkermansia muciniphila induces immune homeostasis in type 1 diabetic mice by up-regulating CD4 + FoxP3 + Treg expression.
Guangzhou, China
Kanpur, India
Mon 18 09:20
RFC13.5
The Development and Validation of Bone-age guided Interpretation of Puberty, a web-based tool for guidance of pubertal disorders
Kanpur, India
Gießen, Germany
Sat 16 14:45
RFC4.5
Ontogenesis of the urinary steroid metabolome in infancy assessed by gas chromatography/mass spectrometry (GC-MS)
Gießen, Germany
Marseille, France
Reggio Emilia, Italy
Mon 18 09:00
RFC14.1
The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life.
Reggio Emilia, Italy
London, UK
Sun 17 15:00
S6.2
New insights into Gonadotrope development
London, UK
Bonn, Germany
Sat 16 14:35
RFC4.3
Differences and similarities in salivary diurnal adrenal hormones in monozygotic twins with intra-twin birthweight-differences
Bonn, Germany
Munich, Germany
Sun 17 12:00
PL4
The importance of chronobiology for medicine – when time matters
Munich, Germany
St.Gallen, Switzerland
Sun 17 09:35
RFC9.2
Effects of the modified release hydrocortisone preparation Efmody® on hormones, spermatogenesis and body weight in males with congenital adrenal hyperplasia
St.Gallen, Switzerland
Naples, Italy
Sun 17 09:30
RFC6.1
Frequency of genetic variants in a population with early-onset obesity: a single center experience
Naples, Italy
Maine, USA
Maryland, USA
Sat 16 11:55
S2.2
Advances in FGF 23 related disorders
Maryland, USA
Seattle, USA
Sun 17 10:50
FC6.6
Novel Melanocortin and Gut-peptide Dual Agonist for Obesity and Diabetes Treatment
Seattle, USA
Paris, France
Minneapolis, USA
Mon 18 10:20
FC15.6
Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study
Minneapolis, USA
Rotterdam, The Netherlands
Sun 17 10:00
FC7.1
Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants
Rotterdam, The Netherlands
London, UK
Mon 18 09:00
HDI2.1
How do I...Manage Fertility Preservation in Young People with Klinefelter syndrome?
London, UK
Minneapolis, United States
Sat 16 15:25
FC4.4
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalystTM Pediatric
Minneapolis, United States
Cambridge, UK
Mon 18 16:30
S9.3
The pathophysiology of transient congenital hypothyroidism
Cambridge, UK
Liverpool, United Kingdom
Odense, Denmark
Mon 18 09:40
FC14.2
Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism.
Odense, Denmark
Kiel, Germany
Sun 17 10:10
FC9.2
Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts
Kiel, Germany
Hertfordshire, United Kingdom
Sun 17 15:30
The patient perspective on new treatment options (example hypogonadotropic hypogonadism)
Hertfordshire, United Kingdom
Lodz, Poland
Sun 17 09:40
RFC7.3
Incidence of false positive results of growth hormone stimulation tests in children with short stature – from theoretical background to clinical approach
Lodz, Poland
Jinan, China
Mon 18 10:10
FC11.5
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
Stanford, USA
Parma, Italy
Mon 18 09:00
RFC13.1
MRI-based radiomics of the pituitary gland is highly predictive of CentralPrecocious Puberty in girls: pilot study
Parma, Italy
Jinan, China
Mon 18 10:10
FC11.5
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
London, United Kingdom
Sat 16 15:15
FC5.3
Gene expression of monosomy X during human development reveals potential mechanisms in Turner syndrome
London, United Kingdom
Cambridge, United Kingdom
Sat 16
Novel insights into the diagnosis of gonadal dysgnesis: findings from the 46,XY gonadal dysgenesis study based on the I-DSD Registry
Cambridge, United Kingdom
Genoa, Italy
Sun 17 10:20
FC6.3
SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention
Genoa, Italy
Liverpool, UK
Sat 16 16:15
PL2
Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Liverpool, UK
Modena, Italy
Sun 17 10:50
FC9.6
The Gender Identity Questionnaire for Children: a useful tool for gender identity detection in early life
Modena, Italy
Florence, Italy
Mon 18 09:25
RFC13.6
Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism
Florence, Italy
Amsterdam, The Netherlands
Istanbul, Turkey
Sat 16 14:50
RFC3.6
Final Height and Endocrine Complications in Children with Pilocytic Astrocytomas: A Retrospective Study
Istanbul, Turkey
Ramat Gan, Israel
Sun 17 15:00
S8.2
Impact of adolescent obesity on adult morbidity and mortality
Ramat Gan, Israel
Istanbul, Turkey
Sat 16 14:35
RFC3.3
Analysis of the expression levels of spexin and kisspeptin in serum, ovarian tissue and white adipose tissue as related to pubertal status and metabolic surrogates of puberty in female albino Wistar rats
Istanbul, Turkey
Rotterdam, The Netherlands
Sat 16 16:55
MTE3.1
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Sun 17 14:35
Mon 18 08:00
MTE3.2
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Hertogenbosch, The Netherlands
Sat 16 15:25
FC1.4
A personalized approach to classify the degree of liver insulin resistance in children with obesity
Hertogenbosch, The Netherlands
Helsinki, Finland
Mon 18 15:30
S11.1
Bangkok, Thailand
Mon 18 09:05
RFC12.2
Prevalence and etiology of thyroid disorders and Characteristic of thyroid function tests in preterm infants
Bangkok, Thailand
Brussels, Belgium
Mon 18 10:10
FC13.5
Rising in body mass index during childhood in girls with idiopathic CPP : a 20-year experience in a tertiary Belgian centre.
Brussels, Belgium
Italy
Mon 18 09:20
RFC12.5
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Copenhagen, Denmark
Sat 16 14:40
RFC3.4
Longitudinal Changes in Serum DLK1 Concentrations During Pubertal Transition in Healthy Girls and in girls with Precocious Puberty during GnRHa treatment
Copenhagen, Denmark
Milan , Italy
Mon 18 09:20
RFC12.5
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Rotterdam, The Netherlands
Sun 17 09:50
RFC7.5
HEALTH-RELATED QUALITY OF LIFE AT MID-PUBERTY IN ADOLESCENTS WITH IDIOPATHIC ISOLATED GROWTH HORMONE DEFICIENCY
Rotterdam, The Netherlands
Ulm, Germany
Sun 17 10:40
FC6.5
FIRST CROSS SECTIONAL ANALYSIS OF THE ECLIP REGISTRY
Ulm, Germany
Germany
Zurich, Switzerland
Sat 16 11:25
S2.1
Phosphate sensing in normal physiology and disease
Zurich, Switzerland
Shanghai, China
Sat 16 14:45
RFC2.5
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Sat 16 14:45
RFC2.5
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Jinan, China
Mon 18 09:10
RFC14.3
Complex Glycerol Kinase Deficiency: four new cases and a review of the literature
Jinan, China
London, UK
Sat 16 08:30
Salzburg, Austria
Sat 16 14:55
HDI1.2
How do I...Handle GLP-1 analogue treatment in adolescents with obesity
Salzburg, Austria
Duesseldorf, Germany
Mon 18 09:20
RFC15.5
Prevalence and management of modifiable cardiovascular risk factors among adolescents and young adults with type 1 diabetes – a cross-sectional analysis from the Diabetes Prospective Follow-Up Registry DPV
Duesseldorf, Germany
Leipzig, Germany
Sun 17 09:40
RFC6.3
Identification and clinical characterization of new patients with novel monogenic agouti-like obesity trait
Leipzig, Germany
Manchester, United Kingdom
Mon 18 09:20
RFC14.5
The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation.
Manchester, United Kingdom
Liverpool, United Kingdom
Sun 17 14:30
S8.1
Pharmacotherapy of Obesity
Liverpool, United Kingdom
Cambridge, UK
Pittsburgh, USA
Sun 17 09:00
C1.2
Should we restrict height in tall stature? - AGAINST
Pittsburgh, USA
Giessen, Germany
Sun 17 15:00
S5.2
Translational Clinical Applications of Complex Steroidobolome Data
Giessen, Germany
Shanghai, China
Sat 16 14:55
FC2.1
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Suzhou, China
Sun 17 09:50
RFC10.5
GAD-65 antibody positive autoimmune encephalitis with type III autoimmune polyendocrine syndrome: a rare pediatric case report
Suzhou, China
Shanghai, China
Sat 16 14:45
RFC2.5
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Bern, Switzerland
Sun 17 09:40
RFC9.3
Nanoencapsulated Curcumin-Piperine Complex: A Breakthrough in Targeting CYP17A1 for Managing Androgen Excess in Adolescents with PCOS.
Bern, Switzerland
London, United Kingdom
Mon 18 10:00
FC13.4
Relationship between the timing of the physical changes of puberty and total pubertal growth in healthy adolescents: new insights which can provide helpful clinical guidance
London, United Kingdom
Jinan, China
Sun 17 09:35
RFC7.2
Time-Restricted Feeding Restored Growth Hormone Pulsatile Profile in LEAP-2 KO Mice with High Fat Diet
Jinan, China
Istanbul, Turkey
Sat 16
A rare cause of 46, XY gonadal dysgenesis: Case presentation
Istanbul, Turkey
Wuhan, China
Sat 16 15:35
FC3.5
Screening for First Morning Voided (FMV) Urinary Gonadotropin (Gn) in Children with Normal and Precocious Puberty (PP): A Prospective, Multi-Center, Large-Sample based Study in China
Wuhan, China
Hong Kong SAR, China
Sat 16 14:30
RFC2.2
Microarchitectural Alterations in Children with Rheumatological conditions on Long‑term Glucocorticoid Treatment
Hong Kong SAR, China
Ulm, Germany
Sat 16 08:40
Early growth trajectories in chidlren with genetic obesity. A European collaboration project
Ulm, Germany
Zhejiang, China
Sun 17 10:40
FC10.5
Using sno-lncRNAs as potential markers for Prader-Willi syndrome diagnosis
Zhejiang, China
Workshop
0
Oral
0
Expert
0
Plenary
0
Catering and Social
0
Nurse
0
Other
0
Symposium
10
No Session Type
104
Sat 16 08:00
Welcome and Update on Working Group Acitivities - Global Obesity Guidelines
Sat 16 08:15
Pubertal Development in Chinese Children and the Impact of Overnutrition, Lifestyle, and Perinatal Factors
Zhejiang, China
Sat 16 08:40
Early growth trajectories in chidlren with genetic obesity. A European collaboration project
Ulm, Germany
Sat 16 09:20
Sat 16 08:00
Immunological effects of gender affirming hormone treatment
London, UK
Sat 16 08:30
Mental health/psychosocial outcomes versus mental health and brain effects
Chicago, USA
Sat 16 09:00
CORE ENDOCRINE REGISTRY: transgender module – preliminary data and future plans
Ghent, Belgium
Sat 16 08:00
Sat 16 08:30
Sat 16 09:00
Fertility preservation in girls
Edinburgh, UK
Sat 16 08:00
News and doubts around growth and puberty therapy
Umea, Sweden
Sat 16 08:20
Beyond growth and puberty issues in girls with TS
Cincinnati, USA
Sat 16 08:40
Challenges from the adult endocrinologist perspective
Aarhus, Denmark
Sat 16 09:00
To present multi-central experience/data and invite to prospective study
Katowice, Poland
Sat 16 08:10
Sat 16 08:35
Osteogenesis imperfecta, update and the OI XIV Animal model
Pavia, Italy
Sat 16 09:00
A case of osteogenesis imperfecta with Antonella Forlio’s expert opinion
Sat 16
A rare cause of 46, XY gonadal dysgenesis: Case presentation
Istanbul, Turkey
Sat 16
Partial gonadal dysgenesis due to chromosomal mosaicism – a challenging case
Birmingham, UK
Sat 16
Novel insights into the diagnosis of gonadal dysgnesis: findings from the 46,XY gonadal dysgenesis study based on the I-DSD Registry
Cambridge, United Kingdom
Sat 16
Pathophysiology and Management of Dysgenetic Gonads
Ghent, Belgium
Sat 16 08:45
Transition in endocrinology - the challenges - change to Complications after cancer treatment
Sat 16 10:15
PL1
Sat 16 11:25
S1.1
Vascular reactivity and morbidity in DSD
Glasgow, UK
Sat 16 11:55
S1.2
Novel mechanisms leading to DSD (genomic, digenic/ollogenic and non-coding variation)
Paris, France
Sat 16 12:25
S1.3
Hypospadias - surgery and beyond
Stockholm, Sweden
Sat 16 11:25
S2.1
Phosphate sensing in normal physiology and disease
Zurich, Switzerland
Sat 16 11:55
S2.2
Advances in FGF 23 related disorders
Maryland, USA
Sat 16 12:25
S2.3
PTH Resistance Syndromes
Paris, France
Sat 16 11:25
S3.1
National UK Guidelines for the Management of Paediatric Craniopharyngioma
London, UK
Sat 16 11:55
S3.2
Use of MC4R agonist in hypothalamic obesity
Madrid, Spain
Sat 16 12:25
S3.3
Proton Beam Therapy in childhood brain tumours
Tennessee, USA
Sat 16 11:25
S4.1
Use of Verapamil in newly diagnosed T1D
Colorado , USA
Sat 16 11:55
S4.2
Use of GLP1 receptor agonists in Wolfram syndrome
Ixelles, Belgium
Sat 16 12:25
S4.3
Statins and Cardiovascular risk in T1D
Cambridge, UK
Sat 16 14:25
RFC1.1
Perceptions and Experiences of PDSNs on Different Hybrid Closed Loop Systems (HCLS) across Wales
Cardiff, United Kingdom
Sat 16 14:30
RFC1.2
Evaluating Glucose-6-Phosphate Dehydrogenase Enzyme Activity In Children With Type 1 Diabetes Mellitus.
Alexandria, Egypt
Alexandria, Egypt
Sat 16 14:35
RFC1.3
Akkermansia muciniphila induces immune homeostasis in type 1 diabetic mice by up-regulating CD4 + FoxP3 + Treg expression.
Guangzhou, China
Sat 16 14:40
RFC1.4
Children born small for gestational age (SGA) under growth hormone treatment have similarly impaired glucose-insulin metabolism as children with obesity
Leipzig, Germany
Sat 16 14:45
RFC1.5
Evaluation of Arterial Stiffness in Children with Type 1 Diabetes Mellitus Using Speckle Tracking Carotid Strain Ultrasonography: Do Atherosclerotic Changes Begin in Childhood?
Aydın, Turkey
Sat 16 14:50
RFC1.6
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND ITS ASSOCIATION WITH GLYCEMIC CONTROL METRICS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: AN EXPLORATORY STUDY
Verona, Italy
Sat 16 14:25
RFC2.1
Bone and Body Composition after one year of Vosorotide treatment in children with Achondroplasia: a longitudinal prospective study.
Genova, Italy
Sat 16 14:30
RFC2.2
Microarchitectural Alterations in Children with Rheumatological conditions on Long‑term Glucocorticoid Treatment
Hong Kong SAR, China
Sat 16 14:35
RFC2.3
Optimizing the Growth Outcome follow up in Hypophosphatemic Rickets Treated with Burosumab: The Critical Role of Auxological Measurements
Padova, Italy
Sat 16 14:40
RFC2.4
CYP24A1 MUTATIONS:, CLINICAL AND LABORATORY FEATURES IN PATIENTS PRESENTING WITH HYPERCALCEMIA
Istanbul, Turkey
Sat 16 14:45
RFC2.5
Prediction of residual growth potential in adolescent boys by linear regression modeling based on the radiomics features extracted by knee DR images and clinical characteristics
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Sat 16 14:50
RFC2.6
Comparison of two automated bone age evaluation methods in pediatric patients with growth and puberty disorders
Lausanne, Switzerland
Sat 16 14:25
RFC3.1
DNA Methylation profiles in girls with anorexia nervosa and amenorrhea: a pilot study
Naples, Italy
Sat 16 14:30
RFC3.2
Results from a targeted hypopituitarism gene panel in patients with variable congenital hypopituitarism identifies variants in known and novel candidate genes.
London, United Kingdom
Sat 16 14:35
RFC3.3
Analysis of the expression levels of spexin and kisspeptin in serum, ovarian tissue and white adipose tissue as related to pubertal status and metabolic surrogates of puberty in female albino Wistar rats
Istanbul, Turkey
Sat 16 14:40
RFC3.4
Longitudinal Changes in Serum DLK1 Concentrations During Pubertal Transition in Healthy Girls and in girls with Precocious Puberty during GnRHa treatment
Copenhagen, Denmark
Sat 16 14:45
RFC3.5
Long-Term Health Outcomes of Delayed Puberty in Males: A Comprehensive Population-Based Study
Örebro, Sweden
Sat 16 14:50
RFC3.6
Final Height and Endocrine Complications in Children with Pilocytic Astrocytomas: A Retrospective Study
Istanbul, Turkey
Sat 16 14:25
RFC4.1
Screening for Adrenal Insufficiency in Children by Home Waking Salivary Cortisone testing
Liverpool, UK
Sat 16 14:30
RFC4.2
Salivary cortisol and cortisone is related to age
Liverpool, United Kingdon
Sat 16 14:35
RFC4.3
Differences and similarities in salivary diurnal adrenal hormones in monozygotic twins with intra-twin birthweight-differences
Bonn, Germany
Sat 16 14:40
RFC4.4
Serum cortisol correlates strongly with salivary cortisol and cortisone in girls and boys, and across all ages
Liverpool, United Kingdom
Sat 16 14:45
RFC4.5
Ontogenesis of the urinary steroid metabolome in infancy assessed by gas chromatography/mass spectrometry (GC-MS)
Gießen, Germany
Sat 16 14:50
RFC4.6
Machine Learning-Based Decision Tree Model for the Diagnosis of Congenital Disorders of Adrenal Steroidogenesis Using LC-MS/MS-based Plasma Steroid Hormone Profiles
Istanbul, Turkey
Sat 16 14:25
RFC5.1
ABOUT CARING FOR PATIENTS AND UNDERSTANDING THEIR PATHWAYS: 10 YEARS OF ‘THE ROTTERDAM CENTRE FOR ADULTS WITH RARE GENETIC SYNDROMES’
Rotterdam, The Netherlands
Sat 16 14:30
RFC5.2
The development and validation of Bone age-guided Interpretation of Growth (BIG), a web-based tool for the guidance of evaluation of children and adolescents with growth disorders.
kanpur, India
Sat 16 14:35
RFC5.3
Neuroradiological Findings in Noonan Syndrome: a multicentric Italian study
Genova, Italy
Sat 16 14:40
RFC5.4
Analysis of growth patterns in Klinefelter syndrome using the QEPS growth model
Gothenburg, Sweden
Sat 16 14:45
RFC5.5
Searching for associated dysmorphic and cardiac abnormalities in youth tall basketball players
Prague, Czech republic
Sat 16 14:50
RFC5.6
Pubertal induction in girls with Turner syndrome – retrospective data from the International TS registry
Katowice, Poland
Sat 16 14:55
FC1.1
Does Type 1 Diabetes Effect Left Ventricular Function in Children? Evaluation with Treadmill Exercise Stress Echocardiography
Izmir, Turkey
Sat 16 15:05
FC1.2
EFFECT OF HYDROXYCHLOROQUINE THERAPY IN NEWLY DIAGNOSED TYPE 1 DIABETES: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROL PILOT TRIAL
Chandigarh, India
Sat 16 15:15
FC1.3
A Non-Invasive Diagnostic Tool for Early Detection of Microvascular Alterations in Children with Type 1 Diabetes Mellitus: Nail-Fold Capillaroscopy
Izmir, Turkey
Sat 16 15:25
FC1.4
A personalized approach to classify the degree of liver insulin resistance in children with obesity
Hertogenbosch, The Netherlands
Sat 16 15:35
FC1.5
The Side-Effects of Lanreotide in Children with Congenital Hyperinsulinism (CHI): A Decade-long Exploration
Basildon, United Kingdom
Sat 16 15:45
FC1.6
Comprehensive rescreening of the known congenital hyperinsulinism genes provides a new genetic diagnosis for 18% of the Finnish cohort
Exeter, United Kingdom
Sat 16 14:55
FC2.1
A highly selective FGFR3 inhibitor alleviates achondroplasia symptoms and restores chondrocyte growth in mice model
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Shanghai, China
Sat 16 15:05
FC2.2
Therapeutic Effects of Human Bone Marrow Mesenchymal Stem Cells Derived Exosomes on Glucocorticoid-Induced Osteoporosis: In Vitro Model
İstanbul, Turkey
Sat 16 15:15
FC2.3
Molecular mechanism of FBN1 variants result to acromicric dysplasia by mechano-transduction
Hangzhou, China
Sat 16 15:25
FC2.4
Analysis of baseline data from the SUNFLOWER longitudinal, observational cohort study of patients with XLH: relationship between various complications and QOL
Tottori, Japan
Sat 16 15:35
FC2.5
Bone health in adolescents with cow’s milk allergy during infancy
Helsinki, Finland
Sat 16 15:45
FC2.6
Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment
Magdeburg, Germany
Sat 16 14:55
FC3.1
The Effects of Blue Light Exposure on the Epiphyseal Plate and IGF1 - IGFBP3 Expression in Rats
Ankara, Turkey
Sat 16 15:05
FC3.2
Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma
London, United Kingdom
Sat 16 15:15
FC3.3
Analysis of clinical factors affecting retinal ganglion cell complex thickness reduction in patients with childhood‑onset craniopharyngioma.
Warsaw, Poland
Sat 16 15:25
FC3.4
The spectrum of Endocrinopathies in Children with Ectopic Posterior Pituitary (EPP) correlates with the severity of associated hypothalamo-pituitary abnormalities on imaging: a decade long experience from two tertiary centers.
Basildon, United Kingdom
Sat 16 15:35
FC3.5
Screening for First Morning Voided (FMV) Urinary Gonadotropin (Gn) in Children with Normal and Precocious Puberty (PP): A Prospective, Multi-Center, Large-Sample based Study in China
Wuhan, China
Sat 16 15:45
FC3.6
Adolescent Acne: Association to Sex, Age, Pubertal Stage and Circulating Concentrations of Testosterone and DHT
Copenhagen, Denmark
Sat 16 14:55
FC4.1
Real world data analysis of contemporary therapy and its association to anthropometric outcomes in 1500 patients with congenital adrenal hyperplasia (CAH).
Sheffield, United Kingdom
Sat 16 15:05
FC4.2
11-oxygenated androgens are abundantly produced by first and second-trimester foetal adrenal glands in ex vivo culture
Birmingham, United Kingdom
Sat 16 15:15
FC4.3
Plasma reference values for C19 oxy-steroids, 11-keto testosterone and 11-keto androstenedione in a paediatric cohort
Kiel, Germany
Sat 16 15:25
FC4.4
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Glucocorticoid Doses in Children and Adolescents with Classic Congenital Adrenal Hyperplasia: Results from CAHtalystTM Pediatric
Minneapolis, United States
Sat 16 15:35
FC4.5
3D printed, personalized hydrocortisone for hypocortisolemia.
Rotterdam, The Netherlands
Sat 16 15:45
FC4.6
Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study
Agios Nikolaos, Greece
Sat 16 14:55
FC5.1
A homozygous variant in ZSWIM6 causes short stature, microcephaly and developmental delay
Prague, Czech Republic
Sat 16 15:05
FC5.2
The pathogenesis of Noonan syndrome and associated growth restriction is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling
London, United Kingdom
Sat 16 15:15
FC5.3
Gene expression of monosomy X during human development reveals potential mechanisms in Turner syndrome
London, United Kingdom
Sat 16 15:25
FC5.4
Predictors of short stature at age 6-7 years in Israeli children
Petach Tikva, Israel
Sat 16 15:35
FC5.5
Phase 2 Trial of Vosoritide Use in patients with Hypochondroplasia: Pharmacokinetic/ Pharmacodynamic analysis from 12 Month Data
Washington DC, United States of America (USA)
Sat 16 15:45
FC5.6
First line treatment evaluation in patients with severe primary insulin-like growth factor 1 deficiency (SPIGFD): Data from the Global Increlex® Registry
Linköping, Sweden
Sat 16 14:55
HDI1.2
How do I...Handle GLP-1 analogue treatment in adolescents with obesity
Salzburg, Austria
Sat 16 16:15
PL2
Addressing Inequalities in Child Health. Lessons from the UK policy experiments in poverty and adversity
Liverpool, UK
Sat 16 16:55
MTE3.1
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Sat 16 16:55
NA1
Relevance of single cell analysis and spatial transcriptomics for endocrine research to unravel new mechanisms?
London, UK
Sun 17 08:35
MTE6.1
Sun 17 08:35
MTE8.1
Sun 17 08:30
C1.1
Should we restrict height in tall stature? - FOR
Stockholm, Sweden
Sun 17 09:00
C1.2
Should we restrict height in tall stature? - AGAINST
Pittsburgh, USA
Sun 17 09:30
ES1.1
Endocrine disrupting effects of over-the-counter mild analgesics such as paracetamol in humans
Copenhagen, Denmark
Sun 17 10:00
ES1.2
Prenatal Exposure to Over-the-Counter Antifugal Drugs Affects Fetal Steroidogenesis and is Associated with Persistent Effects in Children
Copenhagen, Denmark
Sun 17 10:30
ES1.3
Effect of EDCs on the hypothalamic regulation of energy homeostasis and GnRH activity
Liège, Belgium
Sun 17 09:30
RFC6.1
Frequency of genetic variants in a population with early-onset obesity: a single center experience
Naples, Italy
Sun 17 09:35
RFC6.2
Genetic Diagnostic Yield of Obesity
Leipzig, Germany
Sun 17 09:40
RFC6.3
Identification and clinical characterization of new patients with novel monogenic agouti-like obesity trait
Leipzig, Germany
Sun 17 09:45
RFC6.4
Investigation of GNAS Variations as Causes of Monogenic Obesity in Qatar: An Integrative Approach Utilizing In Silico, In Vivo, and In Vitro Studies
Doha, Qatar
Sun 17 09:50
RFC6.5
GRB10 METHYLATION IN UMBILICAL CORD ASSOCIATES POSTNATALLY WITH OBESITY IN HEALTHY CHILDREN
Girona, Spain
Sun 17 09:55
RFC6.6
POTENTIAL ROLE OF ASPG METHYLATION AS A BIOMARKER OF CHILDHOOD OBESITY
Girona, Spain
Sun 17 09:30
RFC7.1
Understanding the molecular basis of short stature in Fanconi Anemia: Impact of pappalysins and stanniocalcins on IGF-I bioavailability
Toledo, Spain
Sun 17 09:35
RFC7.2
Time-Restricted Feeding Restored Growth Hormone Pulsatile Profile in LEAP-2 KO Mice with High Fat Diet
Jinan, China
Sun 17 09:40
RFC7.3
Incidence of false positive results of growth hormone stimulation tests in children with short stature – from theoretical background to clinical approach
Lodz, Poland
Sun 17 09:45
RFC7.4
Use of iSYS-IDS IGF1-Assay Normative Data as a STANDARD in the Diagnosis of Pediatric Growth Hormone Deficiency
ALGIERS, ALGERIA
Sun 17 09:50
RFC7.5
HEALTH-RELATED QUALITY OF LIFE AT MID-PUBERTY IN ADOLESCENTS WITH IDIOPATHIC ISOLATED GROWTH HORMONE DEFICIENCY
Rotterdam, The Netherlands
Sun 17 09:55
RFC7.6
Big data as a strategy in the development of population auxological studies
Vitoria, Spain
Sun 17 09:30
RFC8.1
PREDICT – A randomized investigation of a reduced prenatal dexamethasone dose to reduce virilization in female fetuses with congenital adrenal hyperplasia
Berlin, Germany
Sun 17 09:35
RFC8.2
A Novel Peroxisomal Cause of Primary Adrenal İnsufficiency: Pseudo-neonatal Adrenoleukodystrophy Due to ACOX1 Mutations.
Istanbul, Turkey
Sun 17 09:40
RFC8.3
Multi-hit Model of Primary Adrenal Insufficiency in CPOX mutations
Istanbul, Turkey
Sun 17 09:45
RFC8.4
Rare Genetic Etiology of Primary Adrenal Insufficiency in Children; Clinical and Genetic Characterization Of a Large Sudanese Cohort
Khartoum, Sudan
Sun 17 09:50
RFC8.5
Mitochondrial Nicotinamide Nucleotide Transidrogenase (NNT) and NNT-AS1 impairment is associated with worse outcomes in patients with adrenocortical tumors
Ribeirão Preto, Brazil
Sun 17 09:55
RFC8.6
Prospective evaluation of urinary outcome after partial urogenital sinus mobilization (PUM) for toilet trained female patients with classic congenital adrenal hyperplasia (CAH).
Cairo, Egypt
Cairo, Egypt
Sun 17 09:30
RFC9.1
Prenatal Steroid profiling in 46,XY Disorders of sexual Development (DSD) : A 10 year Retrospective Cohort study
Bron, France
Sun 17 09:35
RFC9.2
Effects of the modified release hydrocortisone preparation Efmody® on hormones, spermatogenesis and body weight in males with congenital adrenal hyperplasia
St.Gallen, Switzerland
Sun 17 09:40
RFC9.3
Nanoencapsulated Curcumin-Piperine Complex: A Breakthrough in Targeting CYP17A1 for Managing Androgen Excess in Adolescents with PCOS.
Bern, Switzerland
Sun 17 09:45
RFC9.4
Testicular function in prepubertal boys with haematological malignancies during and post chemotherapy: a prospective, longitudinal study
Buenos Aires, Argentina
Sun 17 09:50
RFC9.5
Reevaluating Guidelines for Primary Ovarian Insufficiency Workup: Is It Time for a Change?
Ramat Gan, Israel
Sun 17 09:55
RFC9.6
GnRHa TREATMENT OF CRYPTORCHIDISM ALTERS TESTICULAR SUMO GENE EXPRESSION
Liestal, Switzerland
Sun 17 09:30
RFC10.1
Long-Term Endocrine Outcomes of Acute Lymphoblastic Leukemia Treatment with Special Emphasis on the Gonadal Impact
Istanbul, Turkey
Sun 17 09:35
RFC10.2
Ten-year follow up for Children with non-lethal form of Raine Syndrome: Single Center Experience in Oman
Muscat, Oman
Sun 17 09:40
RFC10.3
Anthropometric changes in survivors of childhood acute lymphoblastic leukemia treated on the Italian Association of Pediatric Hematology and Oncology protocols without radiotherapy in the last two decades: preliminary data from an Italian tertiary center.
MODENA, ITALY
Sun 17 09:45
RFC10.4
Manifestation of PTEN and MUTYH gene mutations: A Case Report
Kaunas, Lithuania
Sun 17 09:50
RFC10.5
GAD-65 antibody positive autoimmune encephalitis with type III autoimmune polyendocrine syndrome: a rare pediatric case report
Suzhou, China
Sun 17 09:55
RFC10.6
Different Faces of Carney Complex: Report of Three Cases
Istanbul, Turkey
Sun 17 10:00
FC6.1
Corneal Nerve Loss and regeneration after GLP-1 Therapy in Children with Simple and Monogenic Obesity
Doha, Qatar
Sun 17 10:10
FC6.2
Frequency of Bardet-Biedl syndrome variants in a population with early-onset obesity
Madrid, Spain
Sun 17 10:20
FC6.3
SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention
Genoa, Italy
Sun 17 10:30
FC6.4
Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome
London, United Kingdom
Sun 17 10:40
FC6.5
FIRST CROSS SECTIONAL ANALYSIS OF THE ECLIP REGISTRY
Ulm, Germany
Sun 17 10:50
FC6.6
Novel Melanocortin and Gut-peptide Dual Agonist for Obesity and Diabetes Treatment
Seattle, USA
Sun 17 10:00
FC7.1
Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants
Rotterdam, The Netherlands
Sun 17 10:10
FC7.2
Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups
Prague, Czech Republic
Sun 17 10:20
FC7.3
Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height
Parma, Italy
Sun 17 10:30
FC7.4
Growth Hormone Response to Glucagon Stimulation Test in Transitional Age
Genova, Italy
Sun 17 10:40
FC7.5
Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment
London, United Kingdom
Sun 17 10:50
FC7.6
Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment
Szczecin, Poland
Sun 17 10:00
FC8.1
Quantitative proteomics of pediatric adrenocortical tumors provides insights into zone of origin and identifies overrepresented pathways
Augsburg, Germany
Sun 17 10:10
FC8.2
Detection and differentiation of adrenocortical tumors (ACTs) in children by gas chromatography-mass spectrometry (GC-MS) based urinary steroid metabotyping
Giessen, Germany
Sun 17 10:20
FC8.3
Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant
Brussels, Belgium
Sun 17 10:30
FC8.4
A deep intronic splice variant of CYP11B1 is the most common in Caucasian patients with 11-beta hydroxylase deficiency: functional, clinical and hormonal findings in 36 families
Bron, France
Sun 17 10:40
FC8.5
Free cortisol and free 21-deoxycortisol in the clinical evaluation of adrenal insufficiency in congenital adrenal hyperplasia
Nijmegen, Netherlands
Sun 17 10:50
FC8.6
Plasma concentrations of renin and ACTH in children and adolescents from the general population: new reference intervals according to sex, age, and pubertal stage
Copenhagen, Denmark
Sun 17 10:00
FC9.1
A tiered approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
London, United Kingdom
Sun 17 10:10
FC9.2
Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts
Kiel, Germany
Sun 17 10:20
FC9.3
Prenatal exposure to paracetamol is associated with reduced uterine volume at infancy - A COPANA Cohort study of 302 healthy girls
Copenhagen, Denmark
Sun 17 10:30
FC9.4
Prenatal exposure to paracetamol is associated with smaller testis volume and decreased levels of steroid metabolites during infancy in healthy males: A COPANA cohort study of 287 boys
Copenhagen, Denmark
Sun 17 10:40
FC9.5
Sex hormones shape the skeleton: The impact of puberty suppression and gender affirming hormone therapy on skeletal dimensions in transgender individuals
Amsterdam, The Netherlands
Sun 17 10:50
FC9.6
The Gender Identity Questionnaire for Children: a useful tool for gender identity detection in early life
Modena, Italy
Sun 17 10:00
FC10.1
Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes
London, United Kingdom
Sun 17 10:10
FC10.2
Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918TRET pathogenic variants in children and young people
London, United Kingdom
Sun 17 10:20
FC10.3
Endocrine disorders in a wide cohort of children and adolescents affected by Neurofibromatosis type 1
Milan, Italy
Sun 17 10:30
FC10.4
A novel de novo SAMD9 gene variant causing MIRAGE syndrome associated with steroid-resistant nephrotic syndrome in a 46,XY male.
ATHENS, GREECE
Sun 17 10:40
FC10.5
Using sno-lncRNAs as potential markers for Prader-Willi syndrome diagnosis
Zhejiang, China
Sun 17 10:50
FC10.6
Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective
Riyadh, Saudi Arabia
Sun 17 12:00
PL4
The importance of chronobiology for medicine – when time matters
Munich, Germany
Sun 17 14:35
Sun 17 15:30
The patient perspective on new treatment options (example hypogonadotropic hypogonadism)
Hertfordshire, United Kingdom
Sun 17 14:30
S5.1
Sun 17 15:00
S5.2
Translational Clinical Applications of Complex Steroidobolome Data
Giessen, Germany
Sun 17 15:30
S5.3
Lessons from CAH service evaluation and real world data
Sheffield, UK
Sun 17 14:30
S6.1
Molecular Basis of Congenital Hypopituitarism
Michigan, USA
Sun 17 15:00
S6.2
New insights into Gonadotrope development
London, UK
Sun 17 15:30
S6.3
Management of pituitary stalk thickening in children and young people
London, UK
Sun 17 14:30
S7.1
Stem cells in skeletal development and growth
Texas, USA
Sun 17 15:00
S7.2
Genetic disorders of bone - historic perspectives and novel advances
London, UK
Sun 17 15:30
S7.3
Consensus statement on management of achondroplasia
Nesoddtangen, Norway
Sun 17 14:30
S8.1
Pharmacotherapy of Obesity
Liverpool, United Kingdom
Sun 17 15:00
S8.2
Impact of adolescent obesity on adult morbidity and mortality
Ramat Gan, Israel
Sun 17 15:30
S8.3
Bariatic surgery: impact beyond weight
Boston, USA
Sun 17 16:10
PL5
Mon 18 08:00
MTE3.2
Pharmacological treatment options for adolescents with Obesity
Rotterdam, The Netherlands
Mon 18 08:00
MTE8.2
Mon 18 09:00
HDI2.1
How do I...Manage Fertility Preservation in Young People with Klinefelter syndrome?
London, UK
Mon 18 09:00
RFC11.1
Assessing how the Edmonton Obesity Staging System for Pediatrics (EOSS-P) in childhood relates to later cardiometabolic health compared to other anthropometric measures of obesity
Montreal, Canada
Mon 18 09:05
RFC11.2
Is the Single Point Insulin Sensitivity Estimator (SPISE) index a reliable tool for children and adolescents with overweight/obesity?
Genoa, Italy
Mon 18 09:10
RFC11.3
Ultrasound evaluation of kidney and liver involvement in Bardet-Biedl syndrome
Essen, Germany
Mon 18 09:15
RFC11.4
Association of whole blood amino acid and acylcarnitine metabolome with anthropometry and IGF1 serum levels in healthy children and adolescents
Leipzig, Germany
Mon 18 09:20
RFC11.5
Hepatic lipogenesis increases FGF21 in children/adolescents with obesity.
Verona, Italy
Mon 18 09:25
RFC11.6
Pten knockout in osteoprogenitor cells leads to loss of adipose tissue
Leipzig, Germany
Mon 18 09:00
RFC12.1
From neurology to endocrine: Misdiagnosed MCT8 deficiency
Bursa, Turkey
Mon 18 09:05
RFC12.2
Prevalence and etiology of thyroid disorders and Characteristic of thyroid function tests in preterm infants
Bangkok, Thailand
Mon 18 09:10
RFC12.3
Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism
Baku, Azerbaijan
Mon 18 09:15
RFC12.4
Establishing Outcomes and Management of Mild Neonatal Hyperthyrotropinaemia, a Retrospective Multi-Centre Review
Dublin, Ireland
Mon 18 09:20
RFC12.5
Use of the FT3/FT4 ratio as a predictor of relapse in autoimmune hyperthyroidism: retrospective study on a cohort of 80 pediatric patients
Milan, Italy
Milan , Italy
Italy
Mon 18 09:25
RFC12.6
Evaluation of thyroid nodules in children and adolescents by shear wave elastography (SWE)
Bialystok, Poland
Mon 18 09:00
RFC13.1
MRI-based radiomics of the pituitary gland is highly predictive of CentralPrecocious Puberty in girls: pilot study
Parma, Italy
Mon 18 09:05
RFC13.2
Novel anatomical quantification of all hypothalamic, pituitary, and stalk components predicts the severity of neuroendocrine phenotypes.
London, United Kingdom
Mon 18 09:10
RFC13.3
Unstimulated copeptin and oxytocin concentrations correlate with hypothalamic volumes and posterior pituitary location in congenital and acquired salt-water imbalance disorders.
London, United Kingdom
Mon 18 09:15
RFC13.4
Investigation of Pituitary Function in Langerhans Cell Histiocytosis: A Comprehensive Analysis of Clinical and Radiological Findings
Istanbul, Turkey
Mon 18 09:20
RFC13.5
The Development and Validation of Bone-age guided Interpretation of Puberty, a web-based tool for guidance of pubertal disorders
Kanpur, India
Mon 18 09:25
RFC13.6
Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism
Florence, Italy
Mon 18 09:00
RFC14.1
The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life.
Reggio Emilia, Italy
Mon 18 09:05
RFC14.2
Does gestational diabetes mellitus influence mitochondrial dynamics in offspring?
Istanbul, TURKEY
Mon 18 09:10
RFC14.3
Complex Glycerol Kinase Deficiency: four new cases and a review of the literature
Jinan, China
Mon 18 09:15
RFC14.4
Neurodevelopmental response to nifedipine treatment in an infant with Congenital Hyperinsulinism due to de novo gain-of-function CACNA1D variant.
Mumbai, India
Mon 18 09:20
RFC14.5
The utility of ketones in screening for congenital hyperinsulinism: a retrospective evaluation.
Manchester, United Kingdom
Mon 18 09:25
RFC14.6
Utility of Continuous Glucose Monitoring in hospital monitoring of patients with Hyperinsulinism
Manchester, United Kingdom
Mon 18 09:00
RFC15.1
Altered expression of epigenetic regulators is associated with high infertility risk in patients diagnosed with cryptorchidism.
Liestal, Switzerland
Mon 18 09:05
RFC15.2
Study on effects of poly- and perfluoroalkyl substances on hormones in girls with central precocious puberty
Shanghai, China
Mon 18 09:10
RFC15.3
The different faces of acquired hypothalamic dysfunction.
Utrecht, Netherlands
Mon 18 09:15
RFC15.4
Autoimmunity in children with type 1 diabetes in association with the COVID_19 pandemic - results from the prospective DPV Registry
Bern, Switzerland
Mon 18 09:20
RFC15.5
Prevalence and management of modifiable cardiovascular risk factors among adolescents and young adults with type 1 diabetes – a cross-sectional analysis from the Diabetes Prospective Follow-Up Registry DPV
Duesseldorf, Germany
Mon 18 09:25
RFC15.6
Macrophage switch and iron metabolism regulation by Burosumab in XLH pediatric patients: implications in inflammation and pain modulation.
Naples, Italy
Mon 18 09:30
FC11.1
Frequency of rare syndromic diseases in a population with early-onset obesity
Rome, Italy
Mon 18 09:40
FC11.2
Frequency of rare non-syndromic diseases in a population with early-onset obesity
Madrid, Spain
Mon 18 09:50
FC11.3
Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters
Bari, Italy
Mon 18 10:00
FC11.4
Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies
London, UK
Mon 18 10:10
FC11.5
Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis
Jinan, China
Jinan, China
Jinan, China
Mon 18 10:20
FC11.6
Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years
Rotterdam, The Netherlands
Mon 18 09:30
FC12.1
Use of targeted Next-Generation Sequencing panel in patients with non-autoimmune hypothyroidism: the experience of an Italian Pediatric Endocrinology Center
Bologna, Italy
Mon 18 09:40
FC12.2
Molecular Characterization of Childhood Thyroid Nodules and Thyroid Cancer with DNA/RNA Next Generation Sequencing and Investigation of Phenotype-Genotype Correlation
Ankara, Turkey
Mon 18 09:50
FC12.3
Usefulness of application novel TurboTM TSAb bioassay in the monitoring of pediatric Graves’ patients
Białystok, Poland
Mon 18 10:00
FC12.4
Docosahexaenoic acid (DHA) is reduced and could be protective against Hashimoto’s thyroiditis in children with Down syndrome: a cross-sectional study
Piacenza, Italy
Mon 18 10:10
FC12.5
The Association between Plasma Thyroxine Levels and Attention-Deficit/Hyperactivity Disorder
Izmir, Turkey
Mon 18 10:20
FC12.6
The First Robust Bioavailability/Bioequivalence (BA/BE) Study of Thyromimetic Tiratricol, a Treatment in Development for MCT8 Deficiency.
Stockport, UK
Mon 18 09:30
FC13.1
Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism
Paris, France
Mon 18 09:40
FC13.2
Copy Number Variation (CNV) in Self-limited Delayed Puberty (SLDP)
London, UK
Mon 18 09:50
FC13.3
Effect of Precocious Puberty and GnRHa Treatment on Glucose Metabolism in Female Rats
Guangzhou, China
Mon 18 10:00
FC13.4
Relationship between the timing of the physical changes of puberty and total pubertal growth in healthy adolescents: new insights which can provide helpful clinical guidance
London, United Kingdom
Mon 18 10:10
FC13.5
Rising in body mass index during childhood in girls with idiopathic CPP : a 20-year experience in a tertiary Belgian centre.
Brussels, Belgium
Mon 18 10:20
FC13.6
Voice frequency in healthy children and adolescents: A biomarker of androgen action in puberty
Copenhagen, Denmark
Mon 18 09:30
FC14.1
Non-invasive prenatal testing can detect maternally and paternally inherited variants in the KCNJ11 and ABCC8 genes: implications for clinical management of neonatal diabetes during pregnancy and beyond
Exeter, United Kingdom
Mon 18 09:40
FC14.2
Cord glucose: A normal reference and a potential of an ideal universal screening tool for pathological hyperinsulinism.
Odense, Denmark
Mon 18 09:50
FC14.3
Reduction of Overnight Hypoglycemia in Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study
London, UK
Mon 18 10:00
FC14.4
Efficacy and Safety across Subgroups in Children with Congenital Hyperinsulinism Treated with Dasiglucagon
Manchester, UK
Mon 18 10:10
FC14.5
A novel 94bp deletion in the SLC16A1 promoter causes fasting and exercise-induced hyperinsulinaemic hypoglycaemia
Exeter, United Kingdom
Mon 18 10:20
FC14.6
Patient and Carer Perspectives: A National Survey of Continuous Glucose Monitoring in Children with Congenital Hyperinsulinism in the UK
Cambridge, United Kingdom
Mon 18 09:30
FC15.1
Response to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables
Manchester, United Kingdom
Mon 18 09:40
FC15.2
Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)
Manchester, United Kingdom
Mon 18 09:50
FC15.3
Assessment of actionable secondary genetic findings in a large cohort of children with short stature
Sao Paulo, Brazil
Mon 18 10:00
FC15.4
Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality
London, United Kingdom
Mon 18 10:10
FC15.5
Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities
Herlev, Denmark
Mon 18 10:20
FC15.6
Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study
Minneapolis, USA
Mon 18 11:00
PL6
Pancreatic and islet plasticity in early life: implications for diabetes risk
Tennessee, USA
Mon 18 14:15
MTE6.2
Mon 18 15:30
S9.1
Challenges in congenital hypothyroidism: including genetics, newborn screening and treatment optimization
Paris, France
Mon 18 16:00
S9.2
Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data
Philadelphia, USA
Mon 18 16:30
S9.3
The pathophysiology of transient congenital hypothyroidism
Cambridge, UK
Mon 18 15:30
S10.1
Hypothalamic dysfunction in PWS – research perspective
London, UK
Mon 18 16:00
S10.2
Long-term management and outcomes in PWS
Cambridge, UK
Mon 18 16:30
S10.3
Growth hormone treatment in adults with PWS
Stockholm, Sweden
Mon 18 15:30
S11.1
Mon 18 16:00
S11.2
MAIT cells, an immune link between microbiota and type 1 diabetes
Paris, France
Mon 18 16:30
S11.3
Mon 18 15:30
S12.1
The Role of MiniPuberty in Non-Reproductive Outcomes
Lille, France
Mon 18 16:00
S12.2
Neurodevelopmental syndromes associated with Centra Precocious Puberty
São Paulo, Brazil
Mon 18 16:30
S12.3
Studying the genetic interplay between GnRH deficiency and associated neurocognitive disorders by combining in silico, in vitro and in vivo tools.
Milan, Italy
0 result(s) found.